These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32664150)

  • 21. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
    Liang Z; Mou Q; Pan Z; Zhang Q; Gao G; Cao Y; Gao Z; Pan Z; Feng W
    Med Oncol; 2019 May; 36(6):56. PubMed ID: 31089825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of specific modules and hub genes associated with the progression of gastric cancer.
    Gong C; Hu Y; Zhou M; Yao M; Ning Z; Wang Z; Ren J
    Carcinogenesis; 2019 Oct; 40(10):1269-1277. PubMed ID: 30805585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental Phenol and Paraben Exposure Risks and Their Potential Influence on the Gene Expression Involved in the Prognosis of Prostate Cancer.
    Alwadi D; Felty Q; Roy D; Yoo C; Deoraj A
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the PCA29 gene signature as a predictor in prostate cancer.
    Lee JY; Lin SY; Lin CY; Chuang YH; Huang SH; Tseng YY; Wang HJ; Yang JM
    J Bioinform Comput Biol; 2019 Jun; 17(3):1940006. PubMed ID: 31288639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer.
    Rubicz R; Zhao S; Wright JL; Coleman I; Grasso C; Geybels MS; Leonardson A; Kolb S; April C; Bibikova M; Troyer D; Lance R; Lin DW; Ostrander EA; Nelson PS; Fan JB; Feng Z; Stanford JL
    Mol Oncol; 2017 Feb; 11(2):140-150. PubMed ID: 28145099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer.
    Wang W; Wu Q; Mohyeddin A; Liu Y; Liu Z; Ge J; Zhang B; Shi G; Wang W; Wu D; Wang F
    Comput Math Methods Med; 2022; 2022():5500416. PubMed ID: 36245843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
    Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
    J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
    Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
    Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Bioinformatics Analysis of Master Regulators in Anaplastic Thyroid Carcinoma.
    Pan Z; Li L; Fang Q; Qian Y; Zhang Y; Zhu J; Ge M; Huang P
    Biomed Res Int; 2019; 2019():9734576. PubMed ID: 31183379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five Core Genes Related to the Progression and Prognosis of Hepatocellular Carcinoma Identified by Analysis of a Coexpression Network.
    Kong J; Wang T; Zhang Z; Yang X; Shen S; Wang W
    DNA Cell Biol; 2019 Dec; 38(12):1564-1576. PubMed ID: 31633379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
    Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
    Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
    Lyu F; Li Y; Yan Z; He Q; Cheng L; Zhang P; Liu B; Liu C; Song Y; Xing Y
    J Transl Med; 2022 May; 20(1):202. PubMed ID: 35538543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma.
    Luo Y; Shen D; Chen L; Wang G; Liu X; Qian K; Xiao Y; Wang X; Ju L
    Aging (Albany NY); 2019 Aug; 11(16):6029-6052. PubMed ID: 31422942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.